Evolving Pain Resistance

Grasshopper mice harbor mutations in a pain-transmitting sodium channel that allow them to prey on highly toxic bark scorpions.

Written byJef Akst
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

A southern grasshopper mouse appr oaches and prepares to attack an Arizona bark scorpion. COURTESY OF MATTHEW AND ASHLEE ROWEGrasshopper mice of the southwestern US deserts (Onychomys torridus) have evolved to take advantage of a normally well-protected food source: the Arizona bark scorpion (Centruroides sculpturatus), which produces a toxic, pain-inducing venom that deters most predators. Thanks to a few amino acid changes in a pain-transmitting sodium channel, however, grasshopper mice can consume the venomous arthropods while feeling little or no pain from their sting, according to research published today (October 24) in Science.

“The grasshopper mouse has found a way, very cleverly, to disconnect the pain pathway,” said neuroscientist Thomas Park of the University of Illinois at Chicago, who was not involved in the research. Importantly, he added, this pain resistance is specific to the venom; the mice are still able to feel pain from other stimuli. “There are very useful aspects of pain, [so] you don’t want to be completely insensitive,” he said.

Evolutionary neurobiologist Ashlee Rowe began studying the grasshopper mouse and its bark scorpion prey as a graduate student at North Carolina State University. Early on, she noticed that the mice seemed to be resistant to the scorpion’s sting. “The venom seems to have absolutely no effect whatsoever,” said Rowe, who is now an assistant ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • Jef (an unusual nickname for Jennifer) got her master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses. After four years of diving off the Gulf Coast of Tampa and performing behavioral experiments at the Tennessee Aquarium in Chattanooga, she left research to pursue a career in science writing. As The Scientist's managing editor, Jef edited features and oversaw the production of the TS Digest and quarterly print magazine. In 2022, her feature on uterus transplantation earned first place in the trade category of the Awards for Excellence in Health Care Journalism. She is a member of the National Association of Science Writers.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies